^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    anti-MUC1 CAR-T cells

    i
    Other names: anti-MUC1 CAR-T cells
    Associations
    News
    Trials
    Company:
    Guangdong Pharmaceutical University, Guangzhou Anjie Biomedical Technology
    Drug class:
    MUC1-targeted CAR-T immunotherapy
    Related drugs:
    Associations
    News
    Trials